2 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
Follow Adrenocortical Hyperfunction: new trials by email Literature Review of Adrenocortical Hyperfunction trials Research Report on Adrenocortical Hyperfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nuclear Imaging for Subtype Diagnosis of Primary Aldosteronism [18-F]CETO - Primary Aldosteronism | Phase 2 | Unknown | University of Calgary | 30 | 2023-01-01 | 2024-07-24 |
| Activity of Abiraterone Acetate in the Management of Cushing's Syndrome in Patients With Adrenocortical Carcinoma Abiraterone Acetate - Cushing Syndrome, Adrenocortical Carcinoma | Phase 2 | Unknown | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 10 | 2017-04-18 | 2017-05-10 |
Adrenocortical Carcinoma (1) · Cushing Syndrome (1) · Hyperaldosteronism (1)
Adrenal Gland Diseases (2) · Endocrine System Diseases (2) · Adenocarcinoma (1) · Adrenal Cortex Diseases (1) · Adrenal Cortex Neoplasms (1) · Adrenal Gland Neoplasms (1) · Carcinoma (1) · Endocrine Gland Neoplasms (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1)
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (1) · University of Calgary (1)
Canada (1) · Italy (1)
Alexander Leung, MD (1) · Salvatore Grisanti, MD, PhD (1)
PMID 11745214, PMID 14985252, PMID 16172198, PMID 16580903, PMID 16670169, PMID 18619560, PMID 19223900, PMID 19500762, PMID 21220434, PMID 21612468, PMID 22997446, PMID 23470964, PMID 24210085, PMID 24268504, PMID 26353009
2016 (1)